Chiara Bellio

642 total citations
10 papers, 467 citations indexed

About

Chiara Bellio is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chiara Bellio has authored 10 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Chiara Bellio's work include Cancer, Hypoxia, and Metabolism (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and FOXO transcription factor regulation (2 papers). Chiara Bellio is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and FOXO transcription factor regulation (2 papers). Chiara Bellio collaborates with scholars based in United States, Spain and Italy. Chiara Bellio's co-authors include Giorgia Pilotto, Stefano Indraccolo, Anna Pastò, Alberto Amadori, Maria Ornella Nicoletto, Bo R. Rueda, Chiara Frasson, Micol Silic‐Benussi, Mariangela Manicone and Elisabetta Zulato and has published in prestigious journals such as Cancer Research, Oncogene and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Chiara Bellio

10 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Bellio United States 8 345 245 192 43 43 10 467
Junli Deng China 7 332 1.0× 180 0.7× 198 1.0× 55 1.3× 51 1.2× 8 498
Giorgia Pilotto Italy 10 397 1.2× 257 1.0× 183 1.0× 55 1.3× 25 0.6× 11 550
Florence Giffard France 13 320 0.9× 173 0.7× 90 0.5× 43 1.0× 27 0.6× 23 454
Marie Villedieu France 10 416 1.2× 195 0.8× 151 0.8× 27 0.6× 27 0.6× 10 531
Zhihong Ai China 12 427 1.2× 275 1.1× 117 0.6× 88 2.0× 65 1.5× 23 648
Shanyang He China 13 407 1.2× 253 1.0× 132 0.7× 47 1.1× 38 0.9× 23 552
Himavanth R. Gatla United States 11 362 1.0× 144 0.6× 221 1.2× 112 2.6× 17 0.4× 16 528
Rosario Avolio Italy 13 403 1.2× 230 0.9× 83 0.4× 43 1.0× 29 0.7× 16 533
Xiangyun Zong China 10 252 0.7× 201 0.8× 133 0.7× 26 0.6× 36 0.8× 35 449
Shannon E. Muir United States 6 215 0.6× 76 0.3× 155 0.8× 35 0.8× 40 0.9× 7 399

Countries citing papers authored by Chiara Bellio

Since Specialization
Citations

This map shows the geographic impact of Chiara Bellio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Bellio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Bellio more than expected).

Fields of papers citing papers by Chiara Bellio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Bellio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Bellio. The network helps show where Chiara Bellio may publish in the future.

Co-authorship network of co-authors of Chiara Bellio

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Bellio. A scholar is included among the top collaborators of Chiara Bellio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Bellio. Chiara Bellio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bellio, Chiara, Olga Méndez, Roberta Fasani, et al.. (2023). RAGE/SNAIL1 signaling drives epithelial-mesenchymal plasticity in metastatic triple-negative breast cancer. Oncogene. 42(35). 2610–2628. 2 indexed citations
2.
Bellio, Chiara, Albert Gris‐Oliver, Françesc Canals, et al.. (2022). GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells. Cancers. 14(10). 2562–2562. 12 indexed citations
3.
Bellio, Chiara, Juan M. Durán, Esther Zamora, et al.. (2022). Circulating SOD2 Is a Candidate Response Biomarker for Neoadjuvant Therapy in Breast Cancer. Cancers. 14(16). 3858–3858. 5 indexed citations
4.
Bellio, Chiara, et al.. (2019). The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells. Cancers. 11(11). 1678–1678. 31 indexed citations
5.
Bellio, Chiara, Rosemary Foster, Kaitlyn E. James, et al.. (2018). PARP Inhibition Induces Enrichment of DNA Repair–Proficient CD133 and CD117 Positive Ovarian Cancer Stem Cells. Molecular Cancer Research. 17(2). 431–445. 46 indexed citations
6.
Al-Alem, Linah, et al.. (2018). Ovarian cancer stem cells: What progress have we made?. The International Journal of Biochemistry & Cell Biology. 107. 92–103. 42 indexed citations
7.
Starbuck, Kristen, Linah Al-Alem, David A. Eavarone, et al.. (2018). Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau. Oncotarget. 9(33). 23289–23305. 19 indexed citations
8.
Pastò, Anna, Anna Pagotto, Giorgia Pilotto, et al.. (2016). Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells. Oncotarget. 8(4). 6433–6445. 27 indexed citations
9.
Pastò, Anna, Valentina Serafin, Giorgia Pilotto, et al.. (2014). NOTCH3 Signaling Regulates MUSASHI-1 Expression in Metastatic Colorectal Cancer Cells. Cancer Research. 74(7). 2106–2118. 49 indexed citations
10.
Pastò, Anna, Chiara Bellio, Giorgia Pilotto, et al.. (2014). Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation. Oncotarget. 5(12). 4305–4319. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026